Process View
Any process that stops, prevents, or reduces the frequency, rate or extent of Rho protein signal transduction.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of rho protein signal transduction"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| Lama5 | laminin, alpha 5 | 0.924 | ||
| Itgb3 | integrin beta 3 | 0.881 | Mouse | |
| Kras | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | 0.870 | ||
| Ptk2 | PTK2 protein tyrosine kinase 2 | 0.800 | ||
| Itgb1 | integrin beta 1 (fibronectin receptor beta) | 0.792 | ||
| Pdgfrb | platelet derived growth factor receptor, beta polypeptide | 0.787 | ||
| Nos3 | nitric oxide synthase 3, endothelial cell | 0.637 | ||
| Itga3 | integrin alpha 3 | 0.625 | ||
| Abl1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.540 | Mouse | |
| Vegfa | vascular endothelial growth factor A | 0.534 | ||
| Braf | Braf transforming gene | 0.507 | ||
| Apc | adenomatosis polyposis coli | 0.397 | ||
| Eng | endoglin | 0.387 | ||
| Tgfbr2 | transforming growth factor, beta receptor II | 0.360 | ||
| Pten | phosphatase and tensin homolog | 0.330 | ||
| Hspg2 | perlecan (heparan sulfate proteoglycan 2) | 0.247 | ||
| Ptpn11 | protein tyrosine phosphatase, non-receptor type 11 | 0.231 | ||
| Inpp5d | inositol polyphosphate-5-phosphatase D | 0.229 | ||
| Ric8 | resistance to inhibitors of cholinesterase 8 homolog (C. elegans) | 0.223 | ||
| Cd151 | CD151 antigen | 0.220 | ||
| Notch2 | Notch gene homolog 2 (Drosophila) | 0.219 | ||
| Crim1 | cysteine rich transmembrane BMP regulator 1 (chordin like) | 0.204 | ||
| Selp | selectin, platelet | 0.190 | ||
| Myo1f | myosin IF | 0.177 | ||
| Dok2 | docking protein 2 | 0.170 | ||
| Cd22 | CD22 antigen | 0.166 | ||
| Ptgs2 | prostaglandin-endoperoxide synthase 2 | 0.147 | ||
| Acvrl1 | activin A receptor, type II-like 1 | 0.125 | ||
| Kit | kit oncogene | 0.108 | ||
| Pdgfb | platelet derived growth factor, B polypeptide | 0.092 | ||
| Vhl | von Hippel-Lindau tumor suppressor | 0.087 | ||
| Hif1a | hypoxia inducible factor 1, alpha subunit | 0.084 | ||
| Pcdh12 | protocadherin 12 | 0.079 | ||
| Adcy4 | adenylate cyclase 4 | 0.074 | ||
| Itga6 | integrin alpha 6 | 0.071 | Mouse | |
| Nr3c1 | nuclear receptor subfamily 3, group C, member 1 | 0.069 | ||
| Fgfr1 | fibroblast growth factor receptor 1 | 0.068 | ||
| Bcar1 | breast cancer anti-estrogen resistance 1 | 0.062 | ||
| Itgal | integrin alpha L | 0.060 | Mouse | |
| Ctnnb1 | catenin (cadherin associated protein), beta 1 | 0.059 | ||
| Aplnr | apelin receptor | 0.059 | ||
| Itga5 | integrin alpha 5 (fibronectin receptor alpha) | 0.058 | Mouse | |
| Fas | Fas (TNF receptor superfamily member 6) | 0.057 | ||
| Lyn | Yamaguchi sarcoma viral (v-yes-1) oncogene homolog | 0.056 | ||
| Tln1 | talin 1 | 0.053 | ||
| Itgam | integrin alpha M | 0.051 | Mouse | |
| Pik3cd | phosphatidylinositol 3-kinase catalytic delta polypeptide | 0.049 | ||
| Pdgfra | platelet derived growth factor receptor, alpha polypeptide | 0.049 | ||
| Trp63 | transformation related protein 63 | 0.048 | ||
| Sema6d | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D | 0.046 | ||
| Hbegf | heparin-binding EGF-like growth factor | 0.046 | ||
| Tbx21 | T-box 21 | 0.045 | ||
| Ets1 | E26 avian leukemia oncogene 1, 5' domain | 0.044 | ||
| Hlx | H2.0-like homeobox | 0.044 | ||
| Gja1 | gap junction protein, alpha 1 | 0.043 | ||
| Cdkn1a | cyclin-dependent kinase inhibitor 1A (P21) | 0.043 | ||
| Bcl6b | B-cell CLL/lymphoma 6, member B | 0.043 | Mouse | |
| Smad4 | MAD homolog 4 (Drosophila) | 0.041 | ||
| Nf1 | neurofibromatosis 1 | 0.041 | ||
| Dok1 | docking protein 1 | 0.041 | ||
| Abl2 | v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene) | 0.041 | ||
| Wt1 | Wilms tumor 1 homolog | 0.040 | ||
| Mmp9 | matrix metallopeptidase 9 | 0.040 | ||
| Bcl2 | B-cell leukemia/lymphoma 2 | 0.039 | ||
| Hmha1 | histocompatibility (minor) HA-1 | 0.037 | ||
| Ins2 | insulin II | 0.035 | ||
| Kif3a | kinesin family member 3A | 0.035 | ||
| Mmp14 | matrix metallopeptidase 14 (membrane-inserted) | 0.034 | ||
| Spn | sialophorin | 0.034 | ||
| Cdon | cell adhesion molecule-related/down-regulated by oncogenes | 0.033 | ||
| C5ar1 | complement component 5a receptor 1 | 0.032 | ||
| Lrp1 | low density lipoprotein receptor-related protein 1 | 0.032 | ||
| Slc9a3r2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.032 | ||
| Kitl | kit ligand | 0.032 | ||
| Runx1 | runt related transcription factor 1 | 0.031 | ||
| Ggta1 | glycoprotein galactosyltransferase alpha 1, 3 | 0.029 | ||
| Rock2 | Rho-associated coiled-coil containing protein kinase 2 | 0.028 | ||
| Wasl | Wiskott-Aldrich syndrome-like (human) | 0.028 | ||
| Col4a3 | collagen, type IV, alpha 3 | 0.027 | ||
| Cdh5 | cadherin 5 | 0.026 | ||
| Flt4 | FMS-like tyrosine kinase 4 | 0.025 | ||
| Usp9x | ubiquitin specific peptidase 9, X chromosome | 0.025 | ||
| Tcf21 | transcription factor 21 | 0.025 | ||
| P2rx7 | purinergic receptor P2X, ligand-gated ion channel, 7 | 0.024 | ||
| Il18rap | interleukin 18 receptor accessory protein | 0.023 | ||
| Prdm1 | PR domain containing 1, with ZNF domain | 0.023 | ||
| Dlg1 | discs, large homolog 1 (Drosophila) | 0.023 | ||
| Tgfbr1 | transforming growth factor, beta receptor I | 0.023 | ||
| S1pr4 | sphingosine-1-phosphate receptor 4 | 0.022 | ||
| Cnr2 | cannabinoid receptor 2 (macrophage) | 0.022 | ||
| Klrb1b | killer cell lectin-like receptor subfamily B member 1B | 0.022 | ||
| Nkx2-1 | NK2 homeobox 1 | 0.022 | ||
| Efnb2 | ephrin B2 | 0.021 | ||
| Plec | plectin | 0.021 | ||
| Tbxas1 | thromboxane A synthase 1, platelet | 0.020 | ||
| Pxn | paxillin | 0.020 | ||
| Ppard | peroxisome proliferator activator receptor delta | 0.020 | ||
| Prkci | protein kinase C, iota | 0.019 | ||
| Egfr | epidermal growth factor receptor | 0.019 | ||
| Csf3r | colony stimulating factor 3 receptor (granulocyte) | 0.019 | ||
| Ptpn22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.019 | ||
| Gna15 | guanine nucleotide binding protein, alpha 15 | 0.018 | ||
| Lepr | leptin receptor | 0.018 | ||
| Il10ra | interleukin 10 receptor, alpha | 0.017 | ||
| Ear2 | eosinophil-associated, ribonuclease A family, member 2 | 0.017 | ||
| Lyst | lysosomal trafficking regulator | 0.017 | ||
| Mrc2 | mannose receptor, C type 2 | 0.017 | ||
| Col12a1 | collagen, type XII, alpha 1 | 0.017 | ||
| Cxcr3 | chemokine (C-X-C motif) receptor 3 | 0.017 | ||
| Batf | basic leucine zipper transcription factor, ATF-like | 0.016 | ||
| Def6 | differentially expressed in FDCP 6 | 0.016 | ||
| Prkar2a | protein kinase, cAMP dependent regulatory, type II alpha | 0.016 | ||
| Cdh6 | cadherin 6 | 0.016 | ||
| Tnfrsf1b | tumor necrosis factor receptor superfamily, member 1b | 0.016 | ||
| Epas1 | endothelial PAS domain protein 1 | 0.015 | ||
| Spry4 | sprouty homolog 4 (Drosophila) | 0.015 | ||
| Fli1 | Friend leukemia integration 1 | 0.015 | ||
| Prf1 | perforin 1 (pore forming protein) | 0.014 | ||
| Ret | ret proto-oncogene | 0.014 | ||
| Erbb2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.014 | ||
| Cd180 | CD180 antigen | 0.014 | ||
| Fermt2 | fermitin family homolog 2 (Drosophila) | 0.014 | ||
| Fgf2 | fibroblast growth factor 2 | 0.014 | ||
| Il27ra | interleukin 27 receptor, alpha | 0.014 | ||
| Lamc1 | laminin, gamma 1 | 0.014 | ||
| Nfe2 | nuclear factor, erythroid derived 2 | 0.014 | ||
| Apoe | apolipoprotein E | 0.013 | ||
| Rrm2b | ribonucleotide reductase M2 B (TP53 inducible) | 0.013 | ||
| Cd97 | CD97 antigen | 0.013 | ||
| Mcam | melanoma cell adhesion molecule | 0.013 | ||
| Gm14548 | predicted gene 14548 | 0.013 | ||
| Ushbp1 | Usher syndrome 1C binding protein 1 | 0.013 | ||
| Ncr1 | natural cytotoxicity triggering receptor 1 | 0.013 | ||
| Gcnt2 | glucosaminyl (N-acetyl) transferase 2, I-branching enzyme | 0.013 | ||
| Impad1 | inositol monophosphatase domain containing 1 | 0.013 | ||
| Fgr | Gardner-Rasheed feline sarcoma viral (Fgr) oncogene homolog | 0.013 | ||
| Psen1 | presenilin 1 | 0.013 | ||
| Gp5 | glycoprotein 5 (platelet) | 0.013 | ||
| Pik3cg | phosphoinositide-3-kinase, catalytic, gamma polypeptide | 0.012 | ||
| Gp9 | glycoprotein 9 (platelet) | 0.012 | ||
| S1pr3 | sphingosine-1-phosphate receptor 3 | 0.012 | ||
| Cd38 | CD38 antigen | 0.012 | ||
| Cd40 | CD40 antigen | 0.012 | ||
| Tnks1bp1 | tankyrase 1 binding protein 1 | 0.012 | ||
| Hic1 | hypermethylated in cancer 1 | 0.012 | ||
| Bmpr2 | bone morphogenic protein receptor, type II (serine/threonine kinase) | 0.012 | ||
| Csf1 | colony stimulating factor 1 (macrophage) | 0.012 | ||
| Bmi1 | Bmi1 polycomb ring finger oncogene | 0.012 | ||
| Lmna | lamin A | 0.012 | ||
| Lyl1 | lymphoblastomic leukemia 1 | 0.012 | ||
| Fgd3 | FYVE, RhoGEF and PH domain containing 3 | 0.012 | ||
| Bmpr1a | bone morphogenetic protein receptor, type 1A | 0.012 | ||
| Nos2 | nitric oxide synthase 2, inducible | 0.012 | ||
| Map4k1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.012 | ||
| Fes | feline sarcoma oncogene | 0.012 | ||
| Dll1 | delta-like 1 (Drosophila) | 0.011 | ||
| Mycn | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.011 | ||
| Tgfb1 | transforming growth factor, beta 1 | 0.011 | ||
| Adam17 | a disintegrin and metallopeptidase domain 17 | 0.011 | ||
| Was | Wiskott-Aldrich syndrome homolog (human) | 0.011 | ||
| Pstpip1 | proline-serine-threonine phosphatase-interacting protein 1 | 0.011 | ||
| Bmp5 | bone morphogenetic protein 5 | 0.011 | ||
| Nckap1l | NCK associated protein 1 like | 0.011 | ||
| Xiap | X-linked inhibitor of apoptosis | 0.011 | ||
| Erbb3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.011 | ||
| Plcb3 | phospholipase C, beta 3 | 0.011 | ||
| Thbs1 | thrombospondin 1 | 0.011 | ||
| Sh3bp1 | SH3-domain binding protein 1 | 0.010 | ||
| Trp53 | transformation related protein 53 | 0.010 |